Alexander Lempicki entered the industry of Commercial Medical Research in 1990 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Alex Lempicki by calling (218) 865-4639 during business hours. You can also write to the business’ Single Location at 303a Commonwealth Avenue, Boston, Massachusetts MA 02115. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Alexander Lempicki |
| Representative: | Alex Lempicki |
| Place of Business: | 303a Commonwealth Avenue, Boston, MA 02115 |
| Contact Number: | (218) 865-4639 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 1990 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Alexander Lempicki is a company operating from Suffolk, Massachusetts providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1990 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Alexander Lempicki has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Alex Lempicki at (218) 865-4639 for related queries, or to locate its Single Location using the coordinates 42.350112,-71.085997.
The Single Location can also be found at the street address 303a Commonwealth Avenue in Boston, Massachusetts 02115 and can be engaged online through the company website at , the company Twitter , and Facebook page .